GEORGE SIMEON purchased 1.60M shares of ADARX PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $27.20M. The strongest form of insider conviction signal.
Common Stock
Shares
+3.33M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+1.11M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+512.90K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+592.59K
Price / share
$17.00
Trade value
$10.07M
% of position
Common Stock
Shares
+1.54M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+414.81K
Price / share
$17.00
Trade value
$7.05M
% of position
Common Stock
Shares
+1.67M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+169K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+592.59K
Price / share
$17.00
Trade value
$10.07M
% of position
Net shares
+9.94M
Net value
$27.20M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/28/2026 | C · Conversion | +3.33M | — | — | New position | 0.00 | 3.33M |
| Common Stock Indirect | 9/28/2026 | C · Conversion | +1.11M | — | — | 33.4% | 3.33M | 4.45M |
| Common Stock Indirect | 9/28/2026 | C · Conversion | +512.90K | — | — | 11.5% | 4.45M | 4.96M |
| Common Stock Indirect | 9/28/2026 | P · Purchase | +592.59K | $17.00 | $10.07M | 11.9% | 4.96M | 5.55M |
| Common Stock Indirect | 9/28/2026 | C · Conversion | +1.54M | — | — | New position | 0.00 | 1.54M |
| Common Stock Indirect | 9/28/2026 | P · Purchase | +414.81K | $17.00 | $7.05M | 27.0% | 1.54M | 1.95M |
| Common Stock Indirect | 9/28/2026 | C · Conversion | +1.67M | — | — | New position | 0.00 | 1.67M |
| Common Stock Indirect | 9/28/2026 | C · Conversion | +169K | — | — | 10.1% | 1.67M | 1.84M |
| Common Stock Indirect | 9/28/2026 | P · Purchase | +592.59K | $17.00 | $10.07M | New position | 0.00 | 592.59K |
| Total | +9.94M | $27.20M | ||||||
Series B Preferred Stock
Common Stock
3.33M shares
Shares
−3.91M
Strike price
Held after
0.00
Exercisable
—
Series B-1 Preferred Stock
Common Stock
1.11M shares
Shares
−1.30M
Strike price
Held after
0.00
Exercisable
—
Series C Preferred Stock
Common Stock
512.90K shares
Shares
−600.96K
Strike price
Held after
0.00
Exercisable
—
Series C Preferred Stock
Common Stock
1.54M shares
Shares
−1.80M
Strike price
Held after
0.00
Exercisable
—
Series B Preferred Stock
Common Stock
1.67M shares
Shares
−1.95M
Strike price
Held after
0.00
Exercisable
—
Series B-1 Preferred Stock
Common Stock
169K shares
Shares
−198.02K
Strike price
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series B Preferred Stock Indirect | Common Stock3.33M shares | 9/28/2026 | C · Conversion | −3.91M | — | 0.00 | |
| Series B-1 Preferred Stock Indirect | Common Stock1.11M shares | 9/28/2026 | C · Conversion | −1.30M | — | 0.00 | |
| Series C Preferred Stock Indirect | Common Stock512.90K shares | 9/28/2026 | C · Conversion | −600.96K | — | 0.00 | |
| Series C Preferred Stock Indirect | Common Stock1.54M shares | 9/28/2026 | C · Conversion | −1.80M | — | 0.00 | |
| Series B Preferred Stock Indirect | Common Stock1.67M shares | 9/28/2026 | C · Conversion | −1.95M | — | 0.00 | |
| Series B-1 Preferred Stock Indirect | Common Stock169K shares | 9/28/2026 | C · Conversion | −198.02K | — | 0.00 |